Based in New York City, Adam Nadelson, MD, is an established plastic surgeon who founded and leads The IV Doc. He offers an array of IV therapies in clients’ preferred settings, from the home to the office. Responding to the COVID-19 pandemic, Adam Nadelson, MD, and his team have also developed rapid testing solutions.
With COVID-19 vaccines currently being distributed, one major concern is whether they are effective. Because the body generates antibodies after infection as well as exposure to an effective vaccine, an antibody test can determine if they are present.
The IV Doc’s COVID19 antibody testing approach combines a blood draw with a face-to-face consultation. The latter involves speaking with a board-certified physician via device. This convenient, remote consultation fulfills the same functions as an in-person visit. It allows the physician to gain an understanding of the patient's symptoms and medical history and the discuss the unique testing to the S1 protein THE IV DOC provides. After performing this consultation and evaluating, the physician is able to recommend a treatment. This may include testing for COVID-19, or antibody testing undertaken by a registered nurse, acting under the treating physician’s supervision.
COVID-19 antibody testing helps identify situations where the person has already been exposed to the virus and may have built up immunity (either by having had the disease or by being vaccinated) . It's highly likely that future vaccines will be specific for the Spike 1 (S1) protein inhibition which essentially prevents viral replication. Antibody testing testing has taken on particular significance as vaccinations proceed, as these also results may prove the vaccines effectiveness or if / when a booster may be needed. THE IV DOC's antibody testing program provides accurate results to the S1 protein in New York City and Long Island in as little as 3 hours and outside of New York such as Los Angeles Antibody Testing to the S1 protein in as soon as 24 hours.